Bruker (BRKR) Profit After Tax Growth (1y) (2011 - 2026)
Powered by 
Analysis
Bruker (BRKR) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 240.72 Bn | 236.78 Bn | 8.34 Bn | 7.60% |
| 2 | Danaher | 148.85 Bn | 144.52 Bn | 3.61 Bn | 56.76% |
| 3 | Agilent Technologies | 44.12 Bn | 42.36 Bn | 1.04 Bn | 7.74% |
| 4 | Illumina | 36.18 Bn | 35.01 Bn | 770.00 Mn | -11.91% |
| 5 | Revvity | 16.01 Bn | 14.98 Bn | 416.87 Mn | -3.15% |
| 6 | Bio-Techne | 11.30 Bn | 11.03 Bn | 211.39 Mn | 7,105.94% |
| 7 | Twist Bioscience | 10.47 Bn | 10.30 Bn | 62.45 Mn | -272.06% |
| 8 | Bio-Rad Laboratories | 10.05 Bn | 8.43 Bn | 345.80 Mn | 16.87% |
| 9 | Repligen | 9.98 Bn | 8.97 Bn | 110.04 Mn | -91.79% |
| 10 | Bruker | 9.35 Bn | 9.17 Bn | 416.00 Mn | -784.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -784.21% |
| Mar 31, 2026 | -9.77% |
| Dec 31, 2025 | 107.91% |
| Sep 30, 2025 | -245.72% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -66.54% |
| Dec 31, 2024 | -93.21% |
| Sep 30, 2024 | -53.89% |
| Jun 30, 2024 | -86.85% |
| Mar 31, 2024 | -32.82% |
| Dec 31, 2023 | 108.14% |
| Sep 30, 2023 | 0.34% |
| Jun 30, 2023 | 16.30% |
| Mar 31, 2023 | 24.64% |
| Dec 31, 2022 | 29.34% |
| Sep 30, 2022 | 0.34% |
| Jun 30, 2022 | -32.93% |
| Mar 31, 2022 | 7.44% |
| Dec 31, 2021 | 48.15% |
| Sep 30, 2021 | 37.66% |